Kilitch Drugs (India) consolidated net profit rises 12.50% in the September 2022 quarter
Sales rise 30.25% to Rs 30.70 crore
Net profit of Kilitch Drugs (India) rose 12.50% to Rs 2.43 crore in the quarter ended September 2022 as against Rs 2.16 crore during the previous quarter ended September 2021. Sales rose 30.25% to Rs 30.70 crore in the quarter ended September 2022 as against Rs 23.57 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales30.7023.57 30 OPM %12.8715.53 -PBDT2.443.70 -34 PBT1.553.00 -48 NP2.432.16 13Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 16 2022 | 8:07 AM IST